NY Gov to curb gifts, etc to physicians in USA

25 May 2008

New York State, USA, Governor David Paterson has proposed legislation this month to limit the influence of pharmaceutical manufacturers over prescription decisions. The Governor's bill would ban gifts and payments from drugmakers to physicians and other prescribers in excess of $50 per year. The bill would also require practitioners who make presentations at continuing medical education events to disclose any financial relationship they have with drug firms. In addition, it would increase transparency and promote competition among pharmacy benefit managers by requiring them to disclose information to health plans, doctors and patients.

In his statement, Gov Paterson noted that pharmaceutical manufacturers spend "billions of dollars each year on gifts and payments to doctors," and $1.0 billion annually to support or sponsor at least half of the CME events attended by physicians. The Governor's bill would prohibit a drug manufacturer from giving to a prescriber, and also prevent the latter from accepting payments or gifts that exceed a total of $50 in value in each calendar year. These restrictions would also apply to the prescriber's employees.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight